The preeminence of clusters.
Many cities and countries still view the foundation of a biotech sector as desirable for a high-tech, intellectually driven economy. But a discussion by seasoned biotech management and investors suggests that attaining an environment with the right mix of money, management and innovation remains a difficult and long-term challenge.
Bühler
Fritz
F
European Center of Pharmaceutical Medicine, University Hospital, Basel, Switzerland.
Tang
C Mark
CM
Shah
Pratik
P
Leuchtenberger
Mark
M
Lin
Ko-Chung
KC
Pissarra
Pedro de Noronha
Pde N
D001709:Biotechnology / Q000191:economics* / Q000458:organization & administration*; D003132:Commerce; D019049:Developed Countries / Q000191:economics*; D007449:Investments